(Q44760823)

6 December 2017

Results of a prospective study for the treatment of retinoblastoma (English)

1 reference

6 December 2017

1 reference

Guillermo Chantada

1

1 reference

6 December 2017

Adriana Fandiño

2

1 reference

6 December 2017

María T G Dávila

3

1 reference

6 December 2017

Julio Manzitti

4

1 reference

6 December 2017

Elsa Raslawski

5

1 reference

6 December 2017

Sandra Casak

6

1 reference

6 December 2017

Enrique Schvartzman

7

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

6 December 2017

1 reference

6 December 2017

100

1 reference

6 December 2017

4

1 reference

6 December 2017

834-842

1 reference

High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study

6 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Treatment of overt extraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Extraocular retinoblastoma: a 13-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Phase II window of idarubicin in children with extraocular retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Intrathecal thiotepa: reappraisal of an established therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Overview: chemotherapy for retinoblastoma: an expanding area of clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Results of a stage-based protocol for the treatment of retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Retinoblastoma with low risk for extraocular relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Successful treatment of metastatic retinoblastoma

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FCNCR.11952

21 January 2018

https://api.crossref.org/works/10.1002%2FCNCR.11952

7 January 2021

Etoposide and carboplatin in extraocular retinoblastoma: a study by the Société Française d'Oncologie Pédiatrique

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

Postenucleation adjuvant therapy in high-risk retinoblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

7 January 2021

Intraocular and extraocular retinoblastoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

7 January 2021

Optic nerve invasion of retinoblastoma. Metastatic potential and clinical risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

7 January 2021

Alternative administration of camptothecin analogues

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11952

7 January 2021

Identifiers

DOI

10.1002/CNCR.11952

1 reference

6 December 2017

1 reference